Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
ILA 37.7
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Allium Medical Solutions Ltd. develops, manufactures, and sells long-term, fully covered, expandable, and retrievable stents for the treatment of the various obstructions in the urinary and GI tract in Israel and internationally. The company offers ureteric, bulbar, triangular and round prostatic, and biliary stents. Allium Medical Solutions Ltd. is based in Caesarea, Israel.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers.
Data is available to registered users only
Buy
Sell